End-of-day quote
Other stock markets
|
||
- USD | 0.00% |
May. 06 | Alexion Pharmaceuticals : to bolster rare disease offering with $8.4 billion deal | RE |
Apr. 29 | Mylan NV : Exclusive - Perrigo expected to reject Mylan's latest offer | RE |
- Stock
- Equities
- Stock Pharmacyclics, Inc. - Nasdaq
- News Pharmacyclics, Inc.